Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice

被引:94
作者
Yoshihara, Erni [1 ]
Smeets, Ann [1 ]
Laenen, Annouchka [2 ]
Reynders, Anneleen [1 ]
Soens, Julie [1 ]
Van Ongeval, Chantal [1 ,3 ]
Moerman, Philippe [1 ,4 ]
Paridaens, Robert [1 ,5 ]
Wildiers, Hans [1 ,5 ]
Neven, Patrick [1 ,6 ]
Christiaens, Marie-Rose [1 ]
机构
[1] Univ Hosp Leuven, Multidisciplinaty Breast Ctr, Louvain, Belgium
[2] Catholic Univ Louvain, BIOSTAT, B-3000 Louvain, Belgium
[3] Univ Hosp Leuven, Dept Radiol, Louvain, Belgium
[4] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium
[5] Univ Hosp Leuven, Dept Med Oncol, Louvain, Belgium
[6] Univ Hosp Leuven, Dept Gynecol, Louvain, Belgium
关键词
Breast cancer; Predictors; Lymph node metastases; TUMOR SIZE; MULTIVARIATE-ANALYSIS; CARCINOMA; WOMEN; BIOPSY; INVOLVEMENT; DISSECTION; MORBIDITY; INVASION; RELAPSE;
D O I
10.1016/j.breast.2012.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Lymph node involvement is the most important prognostic factor in breast cancer. It is a multifactorial event determined by patient and tumour characteristics. The purpose of this study was to determine clinical and pathological factors predictive for axillaly lymph node metastasis (ALNM) in patients with early breast cancer and to build a model to portend lymph node involvement. Methods: We evaluated 1300 consecutive patients surgically treated in our institution (2007-2009) for cT1-T2 invasive breast cancer. The patient and tumour characteristics evaluated included: age at diagnosis, number of foci, histologic grade, location, tumour size, histologic subtype, lymphovascular invasion (LVI), estrogen-receptor (ER), progesterone-receptor (PR) and Her-2 status. Univariate and multivariate analyses were performed. Factors significantly associated with ALNM by univariate analysis plus histologic subtype were included in the multivariate analysis. Results: By univariate analysis, the incidence of ALNM was significantly associated with the presence of LVI (P < 0.0001), larger tumour size (P < 0.0001), higher histologic grade (P < 0.0001), retroareolar or lateral location in the breast (P < 0.0001), multiple foci (P = 0.0002) and in patients who underwent an axillary lymph node dissection. We found no effect of age, ER/PR nor HER-2 status. By multivariate analysis, ALNM was significantly associated with the presence of LVI (P < 0.0001), larger tumour size (P < 0.0001), axillary lymph node dissection (P = 0.0003), retroareolar and lateral tumour location in the breast (P = 0.0019) and the presence of multiple foci (P = 0.0155). Conclusions: LVI and tumour size emerged as the most powerful independent predictors of ALNM, followed by the location of the tumour in the breast and the presence of multiple foci. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:357 / 361
页数:5
相关论文
共 32 条
[1]   PREDICTION OF AXILLARY LYMPH-NODE METASTASES IN A SCREENED BREAST-CANCER POPULATION [J].
AHLGREN, J ;
STAL, O ;
WESTMAN, G ;
ARNESSON, LG ;
SUNDEN, M ;
BOERYD, B ;
HATSCHEK, T ;
NORDENSKJOLD, B ;
GRANT, C ;
KALLSTROM, AC ;
NORRBY, S ;
FORDELL, VS ;
BANG, H ;
GUSTAVSSON, R ;
LUNDBERG, S ;
NORBERG, B ;
EINARSSON, E ;
ADLOUNI, W ;
MIKKELSEN, I ;
TEJLER, G ;
HENNING, A ;
MOLDE, A ;
MELLBLOM, L .
ACTA ONCOLOGICA, 1994, 33 (06) :603-608
[2]   Factors Affecting Nodal Status in Invasive Breast Cancer: A Retrospective Analysis of 623 Patients [J].
Aitken, Emma ;
Osman, Monzir .
BREAST JOURNAL, 2010, 16 (03) :271-278
[3]  
Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.3.CO
[4]  
2-8
[5]   A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer [J].
Bevilacqua, JLB ;
Gucciardo, G ;
Cody, HS ;
MacDonald, KA ;
Sacchini, V ;
Borgen, PI ;
Van Zee, KJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (06) :603-614
[6]   A model for predicting axillary node metastases based on 2000 sentinel node procedures and tumour position [J].
Bevilacqua, JLB ;
Cody, HS ;
MacDonald, KA ;
Tan, LK ;
Borgen, PI ;
Van Zee, KJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (05) :490-500
[7]  
Cardoso F, 2008, KCE REPORTS C, V143C, P52
[8]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[9]  
2-H
[10]  
CHADHA M, 1994, CANCER, V73, P350, DOI 10.1002/1097-0142(19940115)73:2<350::AID-CNCR2820730219>3.0.CO